Renal cytochrome P450-related arachidonate metabolite inhibits (Na + + K+)ATPase

Nature

Volumn 314, Issue 6012, 1985, Pages 620-622

  Schwartzman, M ^a   Ferreri, N R ^a   Carroll, M A ^a   Songu Mize, E ^b   McGiff, J C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ARACHIDONIC ACID; ARGIPRESSIN; CALCITONIN; CYTOCHROME P450;

ANIMAL CELL; ENZYME INHIBITION; KIDNEY; KIDNEY TUBULE; METABOLITE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; ARGININE VASOPRESSIN; CALCITONIN; CYTOCHROME P-450 ENZYME SYSTEM; KIDNEY; MALE; NA(+)-K(+)-EXCHANGING ATPASE; RABBITS; VASODILATION; WATER-ELECTROLYTE BALANCE;

ANIMALIA; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0021813222     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/314620a0     Document Type: Article

References (25)

1. Knepper, M. & Burg, M. Am. J. Physiol. 244, F579-F589 (1983).
2. Jørgensen, P. L. Physiol. Rev. 60, 864-917 (1980).
3. Ferreri, N. R., Schwartzman, M., Ibraham, N. G., Chander, P. N. & McGiff, J. C, J. Pharmac. exp. Ther. 231, 441-448 (1984).
4. Grabske, R. J., Lake, S., Gledhill, B. L. & Meistrich, M. L. J. cell PhysioL 86, 177-190 (1975).
5. Hoyer, J. R., Sisson, S. P. & Vernier, R. L. Lab. Invest 41, 168-173 (1979).
6. Copenhaver, W. M., Kelly, D. E. & Wood, R. L. in Bailey's Textbook of Histology (eds Copenhaver, W. M-, Kelly, D. E. & Wood, R. L.) 585-587 (Williams & Wilkins, Baltimore, Maryland, 1978).
7. Vane, J. R. Nature new Biol. 231, 232-235 (1971).
8. Downing, D. T., Ahem, D. G. & Bachta, M. Biochem. biophys. Res. Commun. 40, 218-223 (1970).
9. Testa, B. & Jenner, P. Drug Metab. Rev. 12, 1-117 (1981).
10. Zenser, T. V., Mattammal, M. B. & Davis, B. B. J. Pharmac. exp. Ther. 207, 719-725 (1978).
11. Capdevila, J., Mamett, L. J., Chacos, N., Prough, R. A. & Estabrook, R. W. Proc. natn. Acad. Sci U.S.A. 79, 767-770 (1982).
12. Endou, H. Jap. J. Pharmac. 33, 423-433 (1983).
13. Dees, J. H., Masters, B. S. S., Muller-Eberhard, U. & Johnson, E. F. Cancer Res. 42, 1423-1432 (1982).
14. Morel, F. Am. J. Physiol. 240, F159-F164 (1981).
15. Imbert-Teboul, M., Chabardes, D., Montégut, M., Clique, A. & Morel, F. Endocrinology 102, 1254-1261 (1978).
16. Katz, A. I. Am. J. Physiol. 242, F207-F219 (1982).
17. Williams, C. C, Matthews, E. W., Moseley, J. M. & MacIntyre, I. Clin. Set 42, 129-137 (1972).
18. Fejes-T6th, G. & Szénåsi, G. J. Physiol., Lond. 318, 1-7 (1981).
19. Morel, F. Bull. biol. Fr. Belg. SuppL 39, 136 (1955).
20. Postnov, Y. U., Reznikova, M. & Boriskina, G. Pfliigers Arch. ges. PhysioL 362, 95-99 (1976).
21. Carrara, M. C., Carroll, M. A., McGifï, J. C. & Schwartzman, M. Br. J. Pharmac. Abstr. (in the press).
22. de Wardener, H. E. et al Lancet 1, 411-412 (1981).
23. Overbeck, H. W., Pamnani, M. B., Akera, T., Brody, T. M. & Haddy, F. J. Circulation Res. 38, 11-48-11-52 (1976).
24. Pitts, B. J. R. & Schwartz, A. Biochim. biophys. Acta 401, 184-195 (1975).
25. Martin, J. B. & Doty, D. M. Analyt. Chem. 21, 965-967 (1949).